IMC-EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces Nonobese Diabetic/Severe Combined Immunodeficient Engraftment of Some Acute Lymphoblastic Leukemia Cell Lines and Primary Leukemic Samples
Obdulio Piloto(Pediatric Oncology Group), Donald Small(Johns Hopkins University)
Cited by 44
Related Papers
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation
|Signal Transduction and Targeted Therapy|2021|106
Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study.
|Journal of Clinical Investigation|1991|92